Cost-Effectiveness of Short-Course Radiation Plus Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Among Elderly Patients in China and the United States

• Hoofdauteurs: Jigang Chen (Auteur), Xin Tong (Auteur), Mingyang Han (Auteur), Songfeng Zhao (Auteur), Linjin Ji (Auteur), Yongkai Qin (Auteur), Zilong He (Auteur), Yuesong Pan (Auteur), Chunhui Wang (Auteur), Aihua Liu (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2021-09-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Glioblastoma multiforme (GBM) is a fatal type of brain tumor with a high incidence among elderly people. Temozolomide (TMZ) has proven to be an effective chemotherapeutic agent with significant survival benefits. This study aimed to evaluate the economic outcomes of radiotherapy (RT) and...